It has also been reported that the enforced expression of miR‐19a/b in RA FLS after transfection with its mimic decreased the expression of IL‐6 and MMP‐3, presenting miR‐19a/b as a therapeutic agent for patients with RA to protect from joint inflammation and destruction 11. This evidence concerns the gene MMP3 and rheumatoid arthritis.